Tumor resection fails to better survival in metastatic neuroblastoma

01/31/2013 | Healio

A study in the Journal of Clinical Oncology revealed that primary tumor resection did not improve the five-year, event-free survival in patients with metastatic neuroblastoma. The German researchers said the findings "do not justify aggressive surgery in patients undergoing high-intensity multimodal treatment for metastatic neuroblastoma."

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of Massachusetts
Boston, MA
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide